Safety, pharmacokinetics, and efficacy of asandeutertinib in advanced EGFR-mutated NSCLC: a phase 1 dose-escalation and dose-expansion study
1. 系统已在2025-12-03 11:08:54对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
B Han, J Liu, L Wu, Y Zhao, W Zhang, B Chen…
Journal of Thoracic …, 2025
Elsevier
Introduction This phase 1 study evaluated the safety, pharmacokinetics, and preliminary efficacy
of TY-9591 (asandeutertinib), a deuterated osimertinib derivative. Methods Patients with …

